ICU Medical, Inc. (ICUI)
USD 154.07
(-1.97%)
USD 154.07
(-1.97%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 22.82 Million USD | 555.97% |
| 2022 | -8.7 Million USD | -116.62% |
| 2021 | 52.38 Million USD | 25.29% |
| 2020 | 41.8 Million USD | -33.87% |
| 2019 | 63.22 Million USD | 192.52% |
| 2018 | 21.61 Million USD | 243.33% |
| 2017 | -15.07 Million USD | -118.18% |
| 2016 | 82.94 Million USD | 20.97% |
| 2015 | 68.56 Million USD | 75.64% |
| 2014 | 39.03 Million USD | -24.86% |
| 2013 | 51.94 Million USD | -15.22% |
| 2012 | 61.27 Million USD | -6.05% |
| 2011 | 65.22 Million USD | 32.35% |
| 2010 | 49.27 Million USD | 29.79% |
| 2009 | 37.96 Million USD | 20.98% |
| 2008 | 31.38 Million USD | 27.32% |
| 2007 | 24.64 Million USD | -20.16% |
| 2006 | 30.87 Million USD | 11.88% |
| 2005 | 27.59 Million USD | 366.76% |
| 2004 | 5.91 Million USD | -82.67% |
| 2003 | 34.12 Million USD | 13.75% |
| 2002 | 30 Million USD | 35.63% |
| 2001 | 22.11 Million USD | 33.07% |
| 2000 | 16.62 Million USD | 24.04% |
| 1999 | 13.4 Million USD | 34.0% |
| 1998 | 10 Million USD | 28.21% |
| 1997 | 7.8 Million USD | 30.0% |
| 1996 | 6 Million USD | 11.11% |
| 1995 | 5.4 Million USD | 42.11% |
| 1994 | 3.8 Million USD | -9.52% |
| 1993 | 4.2 Million USD | -10.64% |
| 1992 | 4.7 Million USD | 17.5% |
| 1991 | 4 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 22.79 Million USD | 104.3% |
| 2024 Q1 | 3.76 Million USD | 119.58% |
| 2023 FY | 39.68 Million USD | 555.97% |
| 2023 Q1 | 19.43 Million USD | 139.35% |
| 2023 Q4 | -19.22 Million USD | -184.12% |
| 2023 Q3 | 22.85 Million USD | 728.01% |
| 2023 Q2 | 2.76 Million USD | -85.8% |
| 2022 Q2 | -48 Thousand USD | 99.34% |
| 2022 FY | -8.7 Million USD | -116.62% |
| 2022 Q4 | -49.39 Million USD | -586.69% |
| 2022 Q3 | 10.15 Million USD | 21245.83% |
| 2022 Q1 | -7.25 Million USD | -130.44% |
| 2021 Q2 | 34.47 Million USD | 29.73% |
| 2021 Q3 | 38.38 Million USD | 11.34% |
| 2021 FY | 52.38 Million USD | 25.29% |
| 2021 Q4 | 23.82 Million USD | -37.92% |
| 2021 Q1 | 26.57 Million USD | -1.66% |
| 2020 FY | 41.8 Million USD | -33.87% |
| 2020 Q1 | 26.05 Million USD | 46.2% |
| 2020 Q2 | 19.55 Million USD | -24.95% |
| 2020 Q3 | 25.53 Million USD | 30.55% |
| 2020 Q4 | 27.01 Million USD | 5.83% |
| 2019 Q3 | 32.89 Million USD | 25.25% |
| 2019 Q4 | 17.82 Million USD | -45.83% |
| 2019 Q2 | 26.26 Million USD | -13.52% |
| 2019 FY | 63.22 Million USD | 192.52% |
| 2019 Q1 | 30.37 Million USD | 350.12% |
| 2018 Q4 | -12.14 Million USD | -1570.1% |
| 2018 Q1 | 2.93 Million USD | -92.94% |
| 2018 Q2 | 29.99 Million USD | 923.09% |
| 2018 Q3 | 826 Thousand USD | -97.25% |
| 2018 FY | 21.61 Million USD | 243.33% |
| 2017 Q1 | -16.98 Million USD | -223.32% |
| 2017 Q4 | 41.53 Million USD | 1222.07% |
| 2017 Q3 | -3.7 Million USD | 89.7% |
| 2017 Q2 | -35.93 Million USD | -111.58% |
| 2017 FY | -15.07 Million USD | -118.18% |
| 2016 Q2 | 22.77 Million USD | -4.91% |
| 2016 FY | 82.94 Million USD | 20.97% |
| 2016 Q4 | 13.77 Million USD | -38.67% |
| 2016 Q3 | 22.45 Million USD | -1.38% |
| 2016 Q1 | 23.94 Million USD | 91.53% |
| 2015 FY | 68.56 Million USD | 75.64% |
| 2015 Q4 | 12.5 Million USD | -49.52% |
| 2015 Q1 | 10.97 Million USD | -8.96% |
| 2015 Q3 | 24.76 Million USD | 21.88% |
| 2015 Q2 | 20.32 Million USD | 85.19% |
| 2014 Q3 | 8.4 Million USD | -3.32% |
| 2014 FY | 39.03 Million USD | -24.86% |
| 2014 Q1 | 9.87 Million USD | -27.15% |
| 2014 Q2 | 8.69 Million USD | -11.94% |
| 2014 Q4 | 12.05 Million USD | 43.33% |
| 2013 Q4 | 13.55 Million USD | -12.05% |
| 2013 Q3 | 15.41 Million USD | 40.79% |
| 2013 Q2 | 10.95 Million USD | -8.94% |
| 2013 Q1 | 12.02 Million USD | -36.1% |
| 2013 FY | 51.94 Million USD | -15.22% |
| 2012 FY | 61.27 Million USD | -6.05% |
| 2012 Q2 | 13.54 Million USD | 19.02% |
| 2012 Q3 | 17.53 Million USD | 29.4% |
| 2012 Q4 | 18.81 Million USD | 7.34% |
| 2012 Q1 | 11.38 Million USD | -55.79% |
| 2011 Q2 | 13.98 Million USD | 14.49% |
| 2011 FY | 65.22 Million USD | 32.35% |
| 2011 Q4 | 25.74 Million USD | 93.77% |
| 2011 Q3 | 13.28 Million USD | -4.96% |
| 2011 Q1 | 12.21 Million USD | -25.98% |
| 2010 Q1 | 6.35 Million USD | -41.95% |
| 2010 Q4 | 16.49 Million USD | 12.81% |
| 2010 FY | 49.27 Million USD | 29.79% |
| 2010 Q3 | 14.62 Million USD | 23.9% |
| 2010 Q2 | 11.8 Million USD | 85.76% |
| 2009 Q4 | 10.94 Million USD | 43.33% |
| 2009 FY | 37.96 Million USD | 20.98% |
| 2009 Q1 | 10.71 Million USD | -14.63% |
| 2009 Q2 | 8.66 Million USD | -19.1% |
| 2009 Q3 | 7.63 Million USD | -11.9% |
| 2008 FY | 31.38 Million USD | 27.32% |
| 2008 Q4 | 12.55 Million USD | 19.34% |
| 2008 Q2 | 5.66 Million USD | 114.33% |
| 2008 Q1 | 2.64 Million USD | -60.28% |
| 2008 Q3 | 10.51 Million USD | 85.62% |
| 2007 Q2 | 6.97 Million USD | 30.06% |
| 2007 FY | 24.64 Million USD | -20.16% |
| 2007 Q1 | 5.36 Million USD | 8.67% |
| 2007 Q4 | 6.65 Million USD | 17.87% |
| 2007 Q3 | 5.64 Million USD | -19.09% |
| 2006 Q1 | 9.19 Million USD | 30.24% |
| 2006 Q3 | 8.24 Million USD | -3.07% |
| 2006 Q4 | 4.93 Million USD | -40.09% |
| 2006 FY | 30.87 Million USD | 11.88% |
| 2006 Q2 | 8.5 Million USD | -7.48% |
| 2005 Q2 | 5.72 Million USD | -12.33% |
| 2005 FY | 27.59 Million USD | 366.76% |
| 2005 Q4 | 7.05 Million USD | -14.86% |
| 2005 Q1 | 6.52 Million USD | 291.77% |
| 2005 Q3 | 8.28 Million USD | 44.82% |
| 2004 Q2 | 5.05 Million USD | -19.89% |
| 2004 Q3 | -2.05 Million USD | -140.65% |
| 2004 Q1 | 6.31 Million USD | -39.31% |
| 2004 FY | 5.91 Million USD | -82.67% |
| 2004 Q4 | -3.4 Million USD | -65.56% |
| 2003 Q1 | 11.19 Million USD | 21.91% |
| 2003 FY | 34.12 Million USD | 13.75% |
| 2003 Q4 | 10.4 Million USD | 60.74% |
| 2003 Q2 | 6.05 Million USD | -45.91% |
| 2003 Q3 | 6.47 Million USD | 6.89% |
| 2002 Q2 | 7.57 Million USD | 11.27% |
| 2002 FY | 30 Million USD | 35.63% |
| 2002 Q4 | 9.18 Million USD | 42.64% |
| 2002 Q3 | 6.43 Million USD | -15.01% |
| 2002 Q1 | 6.8 Million USD | -1.69% |
| 2001 Q3 | 4.81 Million USD | -12.4% |
| 2001 Q2 | 5.5 Million USD | 12.84% |
| 2001 Q4 | 6.92 Million USD | 43.68% |
| 2001 Q1 | 4.87 Million USD | -11.4% |
| 2001 FY | 22.11 Million USD | 33.07% |
| 2000 Q2 | 4.16 Million USD | 1.0% |
| 2000 Q4 | 5.5 Million USD | 93.66% |
| 2000 FY | 16.62 Million USD | 24.04% |
| 2000 Q1 | 4.11 Million USD | -4.21% |
| 2000 Q3 | 2.84 Million USD | -31.71% |
| 1999 Q4 | 4.3 Million USD | 53.57% |
| 1999 Q2 | 3.2 Million USD | 3.23% |
| 1999 FY | 13.4 Million USD | 34.0% |
| 1999 Q3 | 2.8 Million USD | -12.5% |
| 1999 Q1 | 3.1 Million USD | 10.71% |
| 1998 Q3 | 2.5 Million USD | 8.7% |
| 1998 Q1 | 2.3 Million USD | 0.0% |
| 1998 FY | 10 Million USD | 28.21% |
| 1998 Q4 | 2.8 Million USD | 12.0% |
| 1998 Q2 | 2.3 Million USD | 0.0% |
| 1997 Q3 | 2 Million USD | 17.65% |
| 1997 Q2 | 1.7 Million USD | -10.53% |
| 1997 Q1 | 1.9 Million USD | 111.11% |
| 1997 FY | 7.8 Million USD | 30.0% |
| 1997 Q4 | 2.3 Million USD | 15.0% |
| 1996 Q2 | 1.6 Million USD | -23.81% |
| 1996 FY | 6 Million USD | 11.11% |
| 1996 Q3 | 1.2 Million USD | -25.0% |
| 1996 Q4 | 900 Thousand USD | -25.0% |
| 1996 Q1 | 2.1 Million USD | 16.67% |
| 1995 Q3 | 1.2 Million USD | -20.0% |
| 1995 Q4 | 1.8 Million USD | 50.0% |
| 1995 Q2 | 1.5 Million USD | 36.36% |
| 1995 FY | 5.4 Million USD | 42.11% |
| 1995 Q1 | 1.1 Million USD | 37.5% |
| 1994 FY | 3.8 Million USD | -9.52% |
| 1994 Q1 | 1.7 Million USD | -5.56% |
| 1994 Q2 | 1.1 Million USD | -35.29% |
| 1994 Q3 | 200 Thousand USD | -81.82% |
| 1994 Q4 | 800 Thousand USD | 300.0% |
| 1993 FY | 4.2 Million USD | -10.64% |
| 1993 Q4 | 1.8 Million USD | 260.0% |
| 1993 Q3 | 500 Thousand USD | -16.67% |
| 1993 Q2 | 600 Thousand USD | -53.85% |
| 1993 Q1 | 1.3 Million USD | 18.18% |
| 1992 Q1 | 1.4 Million USD | 182.35% |
| 1992 Q2 | 1.1 Million USD | -21.43% |
| 1992 Q3 | 1.2 Million USD | 9.09% |
| 1992 Q4 | 1.1 Million USD | -8.33% |
| 1992 FY | 4.7 Million USD | 17.5% |
| 1991 Q1 | 1.9 Million USD | 0.0% |
| 1991 FY | 4 Million USD | 0.0% |
| 1991 Q2 | 1.9 Million USD | 0.0% |
| 1991 Q3 | 1.9 Million USD | 0.0% |
| 1991 Q4 | -1.7 Million USD | -189.47% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -57.66 Million USD | 139.58% |
| AngioDynamics, Inc. | -97.71 Million USD | 123.358% |
| AtriCure, Inc. | -26.68 Million USD | 185.541% |
| Avinger, Inc. | -16.63 Million USD | 237.211% |
| Azenta, Inc. | -73.12 Million USD | 131.213% |
| BioLife Solutions, Inc. | -70.82 Million USD | 132.227% |
| The Cooper Companies, Inc. | 533.1 Million USD | 95.718% |
| Daxor Corporation | -177.07 Thousand USD | 12990.018% |
| Ekso Bionics Holdings, Inc. | -15.11 Million USD | 251.039% |
| Femasys Inc. | -14.5 Million USD | 257.322% |
| GlucoTrack, Inc. | -7.1 Million USD | 421.298% |
| Harvard Bioscience, Inc. | 1.89 Million USD | -1105.121% |
| Hologic, Inc. | 882.6 Million USD | 97.414% |
| Intuitive Surgical, Inc. | 1.76 Billion USD | 98.708% |
| KORU Medical Systems, Inc. | -10.26 Million USD | 322.25% |
| LeMaitre Vascular, Inc. | 37.08 Million USD | 38.447% |
| Innovative Eyewear, Inc. | -6.9 Million USD | 430.771% |
| Innovative Eyewear, Inc. | -6.9 Million USD | 430.771% |
| Masimo Corporation | 136.5 Million USD | 83.278% |
| Microbot Medical Inc. | -9.85 Million USD | 331.608% |
| Meihua International Medical Technologies Co., Ltd. | 14.67 Million USD | -55.537% |
| Merit Medical Systems, Inc. | 123.94 Million USD | 81.584% |
| Nephros, Inc. | -1.59 Million USD | 1532.831% |
| NovoCure Limited | -232.87 Million USD | 109.802% |
| NEXGEL, Inc. | -3.47 Million USD | 756.457% |
| NEXGEL, Inc. | -3.47 Million USD | 756.457% |
| Singular Genomics Systems, Inc. | -102.8 Million USD | 122.203% |
| OraSure Technologies, Inc. | 54.07 Million USD | 57.793% |
| Pro-Dex, Inc. | 7.17 Million USD | -218.207% |
| Pulse Biosciences, Inc. | -43.57 Million USD | 152.382% |
| Predictive Oncology Inc. | -13.92 Million USD | 263.957% |
| Precision Optics Corporation, Inc. | -2.72 Million USD | 937.82% |
| QuidelOrtho Corporation | 139.1 Million USD | 83.591% |
| Repligen Corporation | 54.57 Million USD | 58.178% |
| Sanara MedTech Inc. | -4.21 Million USD | 641.499% |
| STAAR Surgical Company | 28.09 Million USD | 18.764% |
| Sharps Technology, Inc. | -10.12 Million USD | 325.395% |
| Utah Medical Products, Inc. | 16.77 Million USD | -36.049% |
| DENTSPLY SIRONA Inc. | -85 Million USD | 126.853% |
| Jin Medical International Ltd. | 2.86 Million USD | -696.056% |